{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:23:05Z","timestamp":1782861785147,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.clinthera.2008.11.006","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T10:20:57Z","timestamp":1230200457000},"page":"2040-2050","source":"Crossref","is-referenced-by-count":57,"title":["Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007"],"prefix":"10.1016","volume":"30","author":[{"given":"Michael J.","family":"Dowzicky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2008.11.006_bib1","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2007.08.007","article-title":"Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: Findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs","volume":"60","author":"Pillar","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jac\/dkl509","article-title":"Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii","volume":"59","author":"Vila","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib5","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2003"},{"key":"10.1016\/j.clinthera.2008.11.006_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkm310","article-title":"Antimicrobial susceptibility among organisms from the Asia\/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline","volume":"60","author":"Reinert","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib7","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement, M100-S16","year":"2006"},{"key":"10.1016\/j.clinthera.2008.11.006_bib8_1","unstructured":"Tygacil [product insert]. Philadelphia, Pa: Wyeth Pharmaceuticals Inc; 2005."},{"key":"10.1016\/j.clinthera.2008.11.006_bib9","series-title":"Essential Procedures for Clinical Microbiology","author":"Isenberg","year":"1998"},{"key":"10.1016\/j.clinthera.2008.11.006_bib10","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement, M100-S18","year":"2008"},{"key":"10.1016\/j.clinthera.2008.11.006_bib11","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1128\/AAC.00210-06","article-title":"Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial","volume":"50","author":"Waites","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib12","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1128\/JCM.01284-07","article-title":"Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004","volume":"45","author":"Lockhart","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2008.11.006_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib14","unstructured":"Sader H, Fritsche T, Stilwell M, Jones R. Escalating resistance among non-fermentative gram-negative bacilli: Report from the North American SENTRY Antimicrobial Surveillance Program (1997\u20132006). Presented at: 18th European Society of Clinical Microbiology and Infectious Diseases (ESCMID); April 19\u201322, 2008; Barcelona, Spain."},{"key":"10.1016\/j.clinthera.2008.11.006_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-008-0473-y","article-title":"Bloodstream infection due to Acinetobacter spp: Epidemiology, risk factors and impact of multi-drug resistance","volume":"27","author":"Wareham","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/498754","article-title":"Carbapenem susceptibility discords among Acinetobacter isolates","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib17","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/AAC.47.5.1672-1680.2003","article-title":"Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","article-title":"Extended spectrum \u03b2-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment","volume":"63","author":"Rupp","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2008.11.006_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2008.11.006_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.diagmicrobio.2007.05.009","article-title":"Activity of meropenem as serine carbapenemases evolve in US medical centers: Monitoring report from the MYSTIC program (2006)","volume":"59","author":"Rhomberg","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/AAC.47.5.1681-1688.2003","article-title":"Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/dkn149","article-title":"Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005\u201307: Laboratory-based surveillance study","volume":"62","author":"Tillotson","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2008.11.006_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2005.05.005","article-title":"Tigecycline activity tested against 26,474 bloodstream infection isolates: A collection from 6 continents","volume":"52","author":"Sader","year":"2005","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.clinthera.2008.11.006_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diagmicrobio.2005.05.003","article-title":"Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000\u20132004)","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2008.11.006_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/JCM.43.1.462-463.2005","article-title":"Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002)","volume":"43","author":"Treitman","year":"2005","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T10:59:35Z","timestamp":1545562775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808004001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0149291808004001"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.11.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}